** Shares of Oxford Cannabinoid Technologies Holdings
OCTP.L slump as much as 64% to record low of 0.126p; stock
biggest pct loser across London
** The clinical stage biopharmaceutical company focused on
development and commercialisation of cannabinoid medicines
applies for cancellation of listing of shares on LSE main market
** OCTP says its directors, after completion of an internal
strategic review, concluded cancellation of listing will be in
best interest of its business
** Co says it has no near-term cash flow concerns and
remains debt-free
** Stock down 61.4% as of 0938 GMT, pushing YTD losses to
82%
(Reporting by Aby Jose Koilparambil in Bengaluru)
((abyjose.koilparambil@thomsonreuters.com))